MedPath

A Clinical Study to Evaluate the Efficacy and Satisfaction of Ultrasound Therapy Combined With SkinCeuticals A.G.E for Improving Facial Aging

Not Applicable
Recruiting
Conditions
Skin Aging
Interventions
Other: SkinCeuticals A.G.E
Other: standard cream
Registration Number
NCT05748470
Lead Sponsor
Yes Skin Medical Group
Brief Summary

A Prospective, Single-center, Single-blind, Randomized split-face, controlled trial will be conducted. The goal of this clinical trial is to evaluate the efficacy and satisfaction of ultrasound therapy combined with SkinCeuticals A.G.E in improving facial aging, and to explore the medical value of ultrasound therapy combined with SkinCeuticals A.G.E. Participants will be treated with ultrasound combined with SkinCeuticals A.G.E on one randomized side face and ultrasound combined with standard cream on the other side.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Chinese subjects aged 18-65 years inclusive;
  2. The subject 's facial skin is rough, flaccid, and lack of elasticity;
  3. Subjects with multiple facial fine lines (perioral/periocular/forehead, etc.), decree lines or puppet lines area with static fine lines trend, the lower part showed signs of loosening;
  4. Subjects who have consistent facial skin status on both sides and plan to receive ultrasound therapy;
  5. Subjects are willing to follow the requirements of the study protocol and complete the corresponding procedures;
  6. Subjects understand the nature of the study and sign the informed consent form (ICF).
Exclusion Criteria
  1. Subjects with contraindications to ultrasound treatment (such as malignant tumor, acute systemic infection, severe heart disease, bleeding tendency, etc.) or contraindications to A.G.E use (or allergic to other skin care components);
  2. Subjects with facial skin diseases, infection, inflammation or allergic constitution that may affect the judgment of the test results;
  3. Subjects with hypertrophic scar or scar constitution;
  4. Receiving treatment of tightening medical treatment program (Thermage/Fotona 4D/ultrasound/microneedle, etc.) or planning to receive other tightening medical treatment program and drugs during this treatment in the past 3 months;
  5. Patients who have oral or topical cosmetic products that may affect the test results within the past 2 weeks;
  6. Subjects who have participated in drug clinical trials or other trials within the past 30 days (or are participating in), or have used drugs affecting the test results within 1 week;
  7. Female subjects who are pregnant, lactating or plan to become pregnant;
  8. Other subjects who are not suitable for participating in this study as assessed by the investigator.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Test groupSkinCeuticals A.G.E-
Control groupstandard cream-
Primary Outcome Measures
NameTimeMethod
Global aesthetic improvement scale (GAIS) scoreat day 90 after procedure

Investigator Satisfaction Assessment Form. Scoring criteria: 5 (very much improved), 4 (marked improvement), 3 (improved), 2 (no change), or 1 (worse).

Secondary Outcome Measures
NameTimeMethod
Relative change from baseline in dermal thicknessat 30, 60, 90, 180 days after procedure
Relative change from baseline in skin elasticityat 30, 60, 90, 180 days after procedure
Relative change in transepidermal water loss(TEWL) from baselineat 30, 60, 90, 180 days after procedure
Investigator satisfaction assessmentat 30, 60, 90, 180 days after surgery

Investigator Satisfaction Assessment Form. Questions included: 1. Integrated skincare effect of ultrasonic program. 2, Feeling overall improvement of facial wrinkles after using the product. 3, Feeling that the elasticity of facial skin is improved after using the product. 4, Feeling that facial skin fullness improved after using the product. 5. Feeling that the skin moisture is improved after using the product. Satisfaction ratings were divided into: 1: very dissatisfied, 2: dissatisfied, 3: fair, 4: satisfied, and 5: very satisfied, and the proportion of people in each rating was statistically summarized

Global aesthetic improvement scale (GAIS) scoreat day 30,60,180 after procedure

Investigator Satisfaction Assessment Form. Scoring criteria: 5 (very much improved), 4 (marked improvement), 3 (improved), 2 (no change), or 1 (worse).

Subject satisfaction evaluationat 30, 60, 90, 180 days after procedure

Subject Satisfaction Assessment Form. Questions included: 1. Integrated skincare effect of ultrasonic program. 2, Feeling overall improvement of facial wrinkles after using the product. 3, Feeling that the elasticity of facial skin is improved after using the product. 4, Feeling that facial skin fullness improved after using the product. 5. Feeling that the skin moisture is improved after using the product. Satisfaction ratings were divided into: 1: very dissatisfied, 2: dissatisfied, 3: fair, 4: satisfied, and 5: very satisfied, and the proportion of people in each rating was statistically summarized

Change from baseline in fine lines scoreat 30, 60, 90, 180 days after procedure

Skin Parameter Assessment Form. Fine lines: Grading was performed on a Griffith 's scale (10-point scale) with different scores representing: 0 (no fine lines/wrinkles, skin completely smooth and no wrinkles); 1-3 (mild, few fine lines and wrinkles, and distant intervals within the treatment area); 4-6 (moderate, moderate number of fine lines/wrinkles within the treatment area and close to each other); and 7-9 (severe, dense clusters of fine lines/wrinkles within the treatment area). Fine lines status should be evaluated by an independent investigator.

Trial Locations

Locations (1)

Hang Zhou YesSkin Hospital

🇨🇳

Hangzhou, China

© Copyright 2025. All Rights Reserved by MedPath